Back to Search
LANCE LEOPOLD, MD
Hematology & Oncology Physician
NPI: 1386632461Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD044489E(PA)
Research & Publications (15)
Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.
PMID 16224410·Clin Adv Hematol Oncol·2003
4-observational
Acute and long-term toxicities associated with gemtuzumab ozogamicin (Mylotarg) therapy of acute myeloid leukemia.
PMID 11970768·Clin Lymphoma·2002
6-review
The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature.
PMID 12685823·Leuk Lymphoma·2002
6-review
Temperature profiles and bathymetry of some high mountain lakes.
PMID 10841531·Proc Natl Acad Sci U S A·2000
8-other
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.
PMID 19366825·Clin Cancer Res·2009
3-trial
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
PMID 18292288·Blood·2008
7-preclinical
Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.
PMID 17551300·Am J Clin Oncol·2007
3-trial
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.
PMID 17617270·Lancet·2007
3-trial
Random aneuploidy in CML patients at diagnosis and under imatinib treatment.
PMID 16843101·Cancer Genet Cytogenet·2006
2-rct
The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
PMID 16737914·Cancer Genet Cytogenet·2006
4-observational
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
PMID 16116598·Cancer·2005
4-observational
Adsorption of 6-mercaptopurine and 6-mercaptopurine-ribosideon silver colloid: a pH-dependent surface-enhanced Raman spectroscopy and density functional theory study. II. 6-mercaptopurine-riboside.
PMID 15832317·Biopolymers·2005
4-observational
Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapse.
PMID 12448657·Invest New Drugs·2002
6-review
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
PMID 11493443·Blood·2001
8-other
Attributes of an alluvial river and their relation to water policy and management.
PMID 11050220·Proc Natl Acad Sci U S A·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1441 CATLIN WAY
DRESHER, PA 19025 - Phone
- (610) 203-9328
Quick Facts
- NPI
- 1386632461
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile